Form 4 for CRL Charles River Laboratories
Accepted 2023-05-15 00:00:00 ET · period of report 2023-05-11 · accession 0001127602-23-015523 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-15 | 2023-05-11 | CRL | MASSARO GEORGE | Dir | S - Sale | $193.43 | -288 | 4,964 | -5% | -$55.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-11 | S | D | 288 | $193.43 | 4,964 | D | — | — | (F1) This sale occurred pursuant to a 10b5-1 trading plan. |